Risk of thromboembolism in patients with multiple myeloma treated with daratumumab: a systemic review and meta-analysis.
Jiasheng WangYeseong KimPublished in: International journal of hematology (2020)
Daratumumab is associated with lower risk of VTE in clinical trials.